Citi Says Buy the Dip in Bristol-Myers (BMY) Shares

June 26, 2012 8:36 AM EDT Send to a Friend
Get Alerts BMY Hot Sheet
Price: $53.63 +2.15%

Rating Summary:
    11 Buy, 7 Hold, 4 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 24 | Down: 28 | New: 14
Trade BMY Now!
Join SI Premium – FREE
An analyst at Citi is recommending investors buy shares of Bristol-Myers Squibb (NYSE: BMY) following Monday's 3.5 percent decline on the heels of an FDA delay for ELIQUIS. The analyst said the delay is "not substantial."

The stock has not yet traded in Tuesday's pre-open session. Shares closed at $34.13 on the NYSE on Monday.

Visit our Analyst Ratings page to track all the market-moving analyst action on shares of Bristol-Myers.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments

Related Entities

Citi

Add Your Comment